ImmunoIVD AB
ImmunoIVD develops innovative, reliable qPCR assays for newborn screening.
Översikt
- 20–49
- Anställda
- 50–100milj SEK
- Omsättning
- 2015
- Grundat
Nyckelbeslutsfattare
Erna Domsgen
Chief Executive Officer
Beskrivning
ImmunoIVD is a Swedish company established in 2015, specializing in the development of innovative and reliable newborn screening assays. Their core mission is to simplify newborn screening by providing accessible, high-quality diagnostic products for early detection. They manufacture CE IVD marked S...